Astria Therapeutics

ATXS

12.5800.00% ( 0.000 )

Delisted: Oct 12, 09:20:00 (EDT)

Q3 FY2025 Earnings

Financial report interval: 2025.06.30 - 2025.09.30

Overview: Astria Therapeutics(ATXS) the Revenue is 706 K (--%);the EBIT is -34.1 M (-17.54%);the EPS is -0.546 (-28.56%).

Actual

YoY

Estimate

YoY

Vs estimate

YoY

Revenue

0.00B--

----

----

EBIT

-0.03B17.54%

----

----

EPS

-0.545528.56%

----

----

Revenue

ActualEstimateUnit: USD

Quarterly

EBIT

ActualEstimateUnit: USD

Quarterly

Net income

ActualEstimateUnit: USD

Quarterly

EPS

ActualEstimateUnit: USD

Quarterly